The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCizzle Biotech Share News (CIZ)

Share Price Information for Cizzle Biotech (CIZ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.775
Bid: 1.70
Ask: 1.85
Change: 0.075 (4.41%)
Spread: 0.15 (8.824%)
Open: 1.70
High: 1.775
Low: 1.70
Prev. Close: 1.70
CIZ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS: Cizzle Biotechnology loss widens as admin costs mount

Thu, 28th Sep 2023 18:29

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Cizzle Biotechnology Holdings PLC - London diagnostics developer company engaged in developing a blood test for the early detection of the different forms of lung cancer - Reports loss and total comprehensive income for the the six months to June 30 of GBP431,000 widened from GBP390,000 the year before. Basic and diluted loss per share totalled 0.12p compared to LPS of 1.43p before. Administrative expenses rose to GBP457,000 from GBP415,000. Chair Allan Syms said: "The group continued to make excellent progress during the first half of 2023 as key milestones were met in the development of our proprietary assay for the CIZ1B biomarker which is highly associated with early stage lung cancer." Adds: "The priority will be to complete clinical trials and achieve Laboratory Developed Test accreditation and then to expand the use of our CIZ1B antibodies for use in a lateral flow format."

----------

Libertine Holdings PLC - Sheffield, England-based technology platform solutions provider - Reports total income in the 12 twelve months ended March 31 more than halved to GBP1.3 million from GBP2.9 million the year before, while administration expenses near trebled to GBP3.6 million from GBP1.3 million. Pretax loss widened to GBP4.1 million from GBP3.3 million. Commercial revenue in the year were generated from engineering services on a number of customer programmes. The majority of the revenue came from the engineering development with Hyliion on the first phase of our joint development agreement. Grant income in the period relates to a new programme which commenced with BEIS in March 2022. Administrative expenses increased, as a result of investment into core technical development, scale up of the engineering team to support customer contracts and a full year of post-IPO professional fees. States the end of year cash balance was GBP2.5 million, down from GBP6.7 million.

----------

Curzon Energy PLC - London-based investor and developer in US based natural gas projects - Reports pretax loss in the six months to June 30 of USD367,719 narrowed from USD408,424 the year prior. Administrative expenses fell 11% to USD272,656 from USD307,999. Basic loss per share totalled USD0.004 unchanged from the year before. States it is unlikely that the board will recommend a dividend in the foreseeable future. Says efforts during the course of the year were focused on identifying, evaluating and executing an agreement to reverse an exciting opportunity into Curzon. Many potential projects and partners were considered, but the board found the majority lacking in either their ability to execute or in accessing the funding required to progress their respective visions. While progress has been slow, believes that finding the right partnership will be the key to its future and to realizing returns for all stakeholders. Looks forward to announcing a transaction in the near term.

----------

Crossword Cybersecurity PLC - London-based cybersecurity solutions provider - Reports revenue in the six months to June of GBP1.9 million, up 27% from GBP1.5 million the year prior, and a 23% jump in the cost of sales to GBP1.6 million from GBP1.3 million. Pretax loss widened to GBP2.5 million from GBP2.3 million before. Basic loss per share totalled 3 pence compared to 2p last year. States firm has a strong sales pipeline the continued conversion of which will drive revenue to achieve market expectations for the full year to December 31. Targets a drop by half in administrative expenses as a percentage of revenue in 2024 compared to 2022. Believes focus on margin improvement will ensure that there is a clear, carefully managed route to achieving profitability in the medium term. Projects revenue growth rate for 2024 to be circa 30%, to achieve total revenue of circa GBP8 million in 2024. Aims to deliver earnings before interest, tax, depreciation and amortisation and cash breakeven on a monthly basis during the second half of 2024.

----------

Kistos Holdings PLC - London-based energy industry investor - Reports actual revenue in the six months to June 30 of GBP105.1 million, down 24% from GBP137.5 million the year before, due to lower average commodity prices. Pretax loss totalled GBP5.2 million swinging from a pretax profit of GBP102.5 million. Basic earnings per share was 16 pence compared to 63p. Total production reached 1.7 million kilo barrels of oil equivalent, down 25% from 2.2 million kboe last year.

----------

Phoenix Copper Ltd - Base and precious metals explorer in the US state of Idaho - Reports pretax loss in the six months to June 30 of USD625,369 narrowed from USD1.1 million the year prior. Administrative expenses fell to USD617,788 from USD1.1 million before. Loss per share totalled USD0.50 compared to USD0.86. States period-end net assets of USD37.39 million, little changed from USD38.22 million last year. Currently finalising the documentation to create a class of authorised bonds in a total amount of USD300 million, and to admit them to trading on The International Stock Exchange in the Channel Islands, as a prelude to closing an initial tranche to raise up to USD80 million. "We have been in discussion with a number of interested parties for some time, and we are hopeful that we can finally close the book in the near future," company says.

----------

Reabold Resources PLC - Oil and gas company with projects in the UK, US and Romania - Reports zero revenue in the six months to June 30 compared to GBP560,000 last year while administration expenses rose to GBP1.1 million from GBP722,000. Pretax loss widened to GBP3.7 million from GBP2.7 million while loss per share of 4 pence, up from 3p. Sachin Oza and Stephen Williams, co-chief executives commented: "The next 12 months will be exciting for Reabold with anticipated newsflow on our key assets and the expected receipt of the GBP9.5 million contingent payment from Shell (as the balance of the consideration for the Victory project)."

----------

ADM Energy PLC - London-based natural resource investor - Reports zero revenue in the six months to June 30 compared to GBP600,000 the year prior, while administrative expenses more than halved to GBP292,000 from GBP897,000. Pretax loss narrowed to GBP460,000 from GBP834,000 with basic and diluted loss per share of 0.1 pence compared to LPS of 0.3p. Stefan Olivier chief executive said: "We are excited to forge ahead with plans to drill three wells at the Altoona Lease which sits within a major US field, the Midway-Sunset Oilfield."

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
23 Dec 2022 18:15

TRADING UPDATES: Fiinu teams with TransUnion; GRC wins pact

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
23 Nov 2022 16:58

IN BRIEF: Cizzle Biotechnology signs lung-cancer study in China

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Signs further Memorandum of Understanding with International Co-Innovation Centre for Advanced Medical Technology for a clinical pilot study with the Cancer Hospital Chinese Academy of Medical Sciences, National Cancer Center of China. The clinical pilot study will evaluate optimised assays using a monoclonal antibody that Cizzle Biotechnology has developed that specifically detects CIZ1B, which is highly associated with stage 1 lung cancer.

Read more
9 Nov 2022 20:41

UPDATE: Cizzle, Vela Technologies notes planned Conduit Pharma merger

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - and Vela Technologies PLC - Bradford, England-based investment firm focused on early-stage and pre-IPO disruptive technology investments - Notes announcement by Conduit Pharmaceuticals Ltd that it intends to become a publicly traded company on the Nasdaq in the US through a merger with special purpose acquisition firm Murphy Cannon Acquisition Corp. The deal is expected to generate USD149.7 million worth of proceeds for Conduit.

Read more
28 Sep 2022 14:43

Cizzle Biotechnology reports narrowed loss as passes "key milestones"

(Alliance News) - Cizzle Biotechnology Holdings PLC on Wednesday said it had passed "key milestones" as it moved towards generating revenue for its products.

Read more
18 Aug 2022 11:37

Vela Tech, Cizzle Biotech shares jump on investee's trial results

(Alliance News) - Vela Technologies PLC and Cizzle Biotechnology Holdings PLC on Thursday hailed the latest clinical trial results from investee St George Street Capital Ltd.

Read more
5 Jul 2022 12:15

Cizzle Biotechnology expands use of lung cancer test

(Alliance News) - Cizzle Biotechnology Holdings PLC on Tuesday said that it is using its early-stage lung cancer test technology to detect more cancer types, notably breast cancer.

Read more
20 Jun 2022 15:40

UK shareholder meetings calendar - next 7 days

Tuesday 21 June 
1Spatial PLCAGM
Altus Strategies PLCAGM
Coca-Cola HBC AGAGM
FireAngel Safety Technology Group PLCAGM
HC Slingsby PLCAGM
HSS Hire Group PLCAGM
Mission Group PLCAGM
Novacyt SAAGM
Pendragon PLCAGM
RTW Venture Fund LtdAGM
Velocys PLCAGM
Wednesday 22 June 
ASA International Group PLCAGM
Atalaya Mining PLCAGM
Bonhill Group PLCAGM
Chapel Down Group PLCAGM
Churchill China PLCAGM
Downing Renewables & Infrastructure Trust PLCGM re share issue
Ecofin US Renewables Infrastructure Trust PLCAGM
EJF Investments LtdAGM
Frenkel Topping Group PLCAGM
Good Energy Group PLCAGM
Honeycomb Investment Trust PLCAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Intelligent Ultrasound Group PLCAGM
Iofina PLCAGM
John Wood Group PLCAGM
Kingfisher PLCAGM
LXi REIT PLCGM
Menhaden PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Pennant International Group PLCAGM
Plant Health Care PLCAGM
Skillcast Group PLCAGM
Team PLCAGM
Tribal Group PLCGM re final dividend
Trident Royalties PLCAGM
Vertu Motors PLCAGM
Wentworth Resources PLCAGM
Thursday 23 June 
Avacta Group PLCAGM
Anglo Asian Mining PLCAGM
Card Factory PLCAGM
Cordiant Digital Infrastructure LtdAGM
Downing Renewables & Infrastructure Trust PLCGM re initial placing & open offer
Eight Capital Partners PLCGM re aligning 2022 bonds with 2026 bonds
GENinCode PLCAGM
Ideagen PLCGM re takeover by Hg Pooled Management Ltd
Longboat Energy PLCAGM
Oxford Nanopore Technologies PLCAGM
Puma VCT 13 PLCGM re cancellation of listing & liquidation
RBG Holdings PLCAGM
Tandem Group PLCAGM
Union Jack Oil PLCAGM
Zinnwald Lithium PLCAGM
Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
16 Jun 2022 16:55

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 May 2022 12:32

IN BRIEF: Cizzle Biotechnology widens annual loss on acquisition costs

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Posts higher annual loss in 2021. Pretax loss widens to GBP4.0 million from GBP14,000 in 2020. In May 2021, Cizzle was bought by Bould Opportunities PLC. Acquisition-related costs stand at GBP3.1 million in 2021 versus none in 2020.

Read more
6 May 2022 11:18

AIM WINNERS & LOSERS: SDI upbeat; Westminster rises on contract win

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
6 May 2022 10:11

Cizzle Biotechnology shares jump on US lung cancer collaboration

(Alliance News) - Cizzle Biotechnology Holdings PLC on Friday announced a new collaboration into lung cancer testing with a US partner.

Read more
11 Apr 2022 21:14

TRADING UPDATES: WANdisco bookings up; STM legal appeal denied

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
8 Mar 2022 06:45

IN BRIEF: Cizzle Biotech notes promising data from Arcadia study

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Reports that Arcadia clinical study shows potential value of AZD1656 treatment for Covid-19 patients. The new data analysis comes from St George Street Capital Ltd, which runs the trial with Excalibur Medicines Ltd for the treatment, in which Cizzle holds a "significant" royalty-bearing economic interest.

Read more
14 Feb 2022 15:26

Cizzle Biotechnology acquires further 5% interest in Covid treatment

(Alliance News) - Cizzle Biotechnology Holdings PLC shares jumped on Monday after it announced that it acquired an additional 5% interest in the commercialisation of the Covid-19 treatment AZD 1656.

Read more
3 Feb 2022 22:31

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.